HVAX Technolog.
: HVAX · Civil Construction
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock HVAX Technolog.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
HVAX Technologies Limited provides turnkey engineering, procurement, and execution services for controlled environment and cleanroom infrastructure. The company primarily serves the pharmaceutical and healthcare sectors by offering design, consulting, and a wide range of specialized equipment.
Business Model
The company operates as a turnkey solutions provider, generating revenue through the design, engineering, and installation of cleanroom infrastructure. It also acts as a supplier for third-party manufactured components, including electrical panels, HVAC systems, and cleanroom hardware.
- Established:2010
Growth Outlook
Growth is driven by the increasing demand for high-standard cleanroom infrastructure within the pharmaceutical and healthcare industries. The company leverages its turnkey capabilities to capture project-based demand for controlled environment facilities.
Key Risks
- Project Execution Risk. Delays in large-scale infrastructure projects or cost overruns could adversely impact the company's profitability.
- Dependency on Third-Party Suppliers. Reliance on external manufacturers for critical equipment components may expose the company to supply chain disruptions or quality control issues.
- Sector Concentration. The company's heavy reliance on the pharmaceutical and healthcare sectors makes it vulnerable to regulatory changes or capital expenditure cycles within those industries.
- Competitive Intensity. The civil construction and cleanroom infrastructure market is highly fragmented, leading to significant pricing pressure from both established players and smaller regional firms.
Start your research today
Unlock AI insights, financials, peers and live data on HVAX Technolog. and 5,000+ companies — free.
Peers · Civil Construction
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
HVAX Technolog.HVAX | ₹183 Cr | — | — | — | 10.0% | — | — | -19.5% |
IL&FS Engineering and Construction Company LimitedIL&FSENGG | ₹464 Cr | 354.10 | 254.66 | -41.5% | 6.5% | 0.0% | -0.1% | +10.1% |
Vishnu Prakash R Punglia LimitedVPRPL | ₹401 Cr | -2.04 | -7.63 | -43.3% | -19.3% | -27.9% | -21.7% | -75.1% |
Markolines Pavement Technologies LimitedMARKOLINES | ₹382 Cr | 12.62 | 8.44 | — | 13.1% | 14.7% | 21.7% | +2.4% |
Zodiac EnergyZODIAC | ₹374 Cr | 15.42 | 9.00 | — | 11.1% | 21.7% | 22.1% | -36.1% |
GVK Power & Infrastructure LimitedGVKPIL | ₹335 Cr | -53.00 | -181.56 | -100.0% | -355.6% | 0.6% | -0.7% | -34.0% |
As of Mar 2026
Financials
HVAX Technolog.
: HVAX · Civil Construction
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock HVAX Technolog.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
HVAX Technologies Limited provides turnkey engineering, procurement, and execution services for controlled environment and cleanroom infrastructure. The company primarily serves the pharmaceutical and healthcare sectors by offering design, consulting, and a wide range of specialized equipment.
Business Model
The company operates as a turnkey solutions provider, generating revenue through the design, engineering, and installation of cleanroom infrastructure. It also acts as a supplier for third-party manufactured components, including electrical panels, HVAC systems, and cleanroom hardware.
- Established:2010
Growth Outlook
Growth is driven by the increasing demand for high-standard cleanroom infrastructure within the pharmaceutical and healthcare industries. The company leverages its turnkey capabilities to capture project-based demand for controlled environment facilities.
Key Risks
- Project Execution Risk. Delays in large-scale infrastructure projects or cost overruns could adversely impact the company's profitability.
- Dependency on Third-Party Suppliers. Reliance on external manufacturers for critical equipment components may expose the company to supply chain disruptions or quality control issues.
- Sector Concentration. The company's heavy reliance on the pharmaceutical and healthcare sectors makes it vulnerable to regulatory changes or capital expenditure cycles within those industries.
- Competitive Intensity. The civil construction and cleanroom infrastructure market is highly fragmented, leading to significant pricing pressure from both established players and smaller regional firms.
Start your research today
Unlock AI insights, financials, peers and live data on HVAX Technolog. and 5,000+ companies — free.
Peers · Civil Construction
As of Mar 2026